Marked improvement in leptomeningeal carcinomatosis and spinal cord metastases following alectinib treatment of crizotinib-resistant, ALK-positive lung adenocarcinoma
Crossref DOI link: https://doi.org/10.1007/s13691-015-0231-9
Published Online: 2015-07-18
Published Print: 2016-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kuribayashi, Hidehiko
Abe, Shinji
Kuse, Naoyuki
Kusunoki, Yuji
Narato, Ritsuko
Saito, Hitoshi
Gemma, Akihiko
License valid from 2015-07-18